Found 177 matching trials
Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis PHASE2 Novel approaches to improve TB treatment outcomes (to reduce morbidity, mor...
Show More Location
National Center for Tuberculosis and Lung Diseases
Learn More & Join Trial
Bronchial Artery Embolization and Medical Measures in Non Severe Acute Hemoptysis of Mild-moderate Abundance NA Severe hemoptysis is a life-threatening condition, with an unpredictable co...
Show More Location
Tenon Hospital, AP-HP
Learn More & Join Trial
Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment Outcomes PHASE4 Tuberculosis (TB) is a leading cause of death in HIV-infected individuals. ...
Show More Location
Infectious Diseases Institute
Learn More & Join Trial
Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 PHASE4 In countries with a high tuberculosis (TB) prevalence, TB and invasive bact...
Show More Location
Sihanouk Hospital Center of Hope
Learn More & Join Trial
The Safety of Tuberculosis Treatments by Oral Inhalation PHASE1 The inhaled route of delivery has always been associated with the considera...
Show More Location
Songklanagarind Hospital
Learn More & Join Trial
Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity NA Tuberculosis is one of the major health problems in developing countries. I...
Show More Location
National Research Institute of Tuberculosis and Lung Disease (NRITLD)
Learn More & Join Trial
Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis PHASE3 The primary objective is to determine whether Leukotriene A4 hydrolase (LTA...
Show More Location
Hospital for Tropical Diseases
Learn More & Join Trial
Tuberculosis Clinical Registry in Europe N/A The TBnet registry is a multinational, prospective tuberculosis registry es...
Show More Location
Research Center Borstel, Leibniz Lung Center
Learn More & Join Trial
A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis PHASE3 This is a phase 3, open-label, randomized clinical trial in adults and adol...
Show More Location
Perinatal HIV Research Unit, PHRU-Matlosana, Tshepong Hospital
Learn More & Join Trial
Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166) PHASE2 The new drug pyrifazimine (previous name: TBI-166) developed by the Institu...
Show More Location
Beijing Chest Hospital
Learn More & Join Trial